治疗性单采血管通路的管理  

The management of vascular access in therapeutic apheresis

作　　者：江颖 庄远 于洋 JIANG Ying;ZHUANG Yuan;YU Yang(The First Medical Center of the PLA General Hospital,Department of Blood Transfusion Medicine,Beijing 100853,China)

机构地区：[1]中国人民解放军总医院第一医学中心输血医学科,北京100853

出　　处：《中国输血杂志》2025年第1期43-47,共5页Chinese Journal of Blood Transfusion

摘　　要：治疗性单采(TA)目前已被用于血液和非血液性疾病,由于该技术具有疗效可靠、安全性佳、操作简单等优点,被广泛应用于难治和重症疾病患者的临床诊疗中。从操作者的角度,治疗能否顺利完成,在很大程度上取决于能否获得合适的血管通路。笔者对TA过程中血管通路的背景与发展趋势、类型及其优缺点进行归纳总结,用以指导临床操作实践。Therapeutic apheresis(TA)is currently used for both hematological and non-hematological diseases.Due to its reliable efficacy,good safety,and simple operation,TA has been widely used in the clinical diagnosis and treatment of patients with refractory and severe diseases.From the operator′s perspective,the successful completion of treatment largely depends on the appropriate vascular access.This review summarizes the background,development trends,types,advantages and disadvantages of vascular access during the TA process to guide clinical operation practice.

关 键 词：治疗性单采 血管通路 

分 类 号：R457.1[医药卫生—治疗学]